Rates of Respiratory Viral Infection in Pediatric Lung Transplant Patients After ATG vs. Basiliximab Induction

被引：0
|
作者：
Henderson, C. [1 ]
Nicholas, S. [1 ]
Munoz-Rivas, F. [1 ]
Melicoff-Portillo, E. [1 ]
Das, S. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5133
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Comparing the Rate of Opportunistic Infection after Renal Transplant between Alemtuzumab and Basiliximab for Induction Immunosuppression.
    Seaman, J. A.
    Westphal, S. G.
    Qiu, F.
    Bremers, D.
    Florescu, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 824 - 824
  • [32] Preceeding Respiratory Viral Infection Is a Strong Risk Factor for Fungal infection in Lung Transplant Recipients
    Hopkins, P. M. A.
    Kermeen, F. D.
    Tsang, B.
    Daniels, T. W. V.
    Seale, H.
    Bec, C.
    Chambers, D. C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S160 - S160
  • [33] Use of Oral Ribavirin for Respiratory Viral Infections in Lung Transplant Patients
    Garcia, B.
    Sharma, N.
    Johnson, K.
    Diaz, E.
    Wille, K.
    Salgado, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S308 - S309
  • [34] Respiratory Viral Infections in Pediatric Lung Transplant Recipients Are Not Associated with BOS, Retransplant or Death
    Sweet, S. C.
    Buller, R.
    Chin, H.
    Conrad, C.
    Faro, A.
    Goldfarb, S.
    Hayes, D.
    Heeger, P.
    Ikle, D.
    Kesler, K.
    Melicoff-Portillo, E.
    Mohanakumar, T.
    Schecter, M.
    Storch, G.
    Visner, G.
    Williams, N.
    Danziger-Isakov, L.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S119 - S119
  • [35] PARAINFLUENZA VIRAL INFECTION AFTER LUNG TRANSPLANT: NOT JUST ANOTHER CARV
    Mark, Benzimira
    Chien-Li, Liew
    Kathryn, Hanning
    Adrian, Havryk
    Marshall, Plit
    Monique, Malouf
    Allan, Glanville
    IMMUNOLOGY AND CELL BIOLOGY, 2009, 87 (06): : A26 - A26
  • [36] Similar Survival in Patients Following Heart Transplantation Receiving Induction Therapy Using Daclizumab vs. Basiliximab
    Martin, Spencer T.
    Kato, Tomoko S.
    Farr, Maryjane
    McKeen, Jaclyn T.
    Cheema, Faisal
    Ji, Mengxi
    Ross, Alexandra
    Yerebakan, Halit
    Naka, Yoshifumi
    Takayama, Hiroo
    Restaino, Susan
    Mancini, Donna
    Schulze, Christian
    CIRCULATION JOURNAL, 2015, 79 (02) : 368 - 374
  • [37] Perioperative Tacrolimus Levels Do Not Impact Early Acute Rejection Rates in Lung Transplant Recipients Receiving Basiliximab Induction
    Lawrence, S. E.
    Schoeppler, K.
    Sartain, E.
    Smith, J.
    Steele, M. P.
    Gray, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S501 - S501
  • [38] Basiliximab vs. Low-Dose Thymoglobulin Induction Therapy in Low Risk Kidney Transplant Patients: Prospective Randomized Study in Southeastern Mexico.
    Martinez-Mier, G.
    Moreno-Ley, P. I.
    Budar-Fernandez, L. F.
    Mendez-Lopez, M. T.
    Barrera-Amoros, D. A.
    De la Paz-Roman, M.
    Jimenez-Lopez, L. A.
    Aguilar-Sandoval, E. G.
    Allende-Castellanos, C. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 822 - 823
  • [39] The Burden of Influenza Infection and Disease in Pediatric Lung Transplant Patients
    Hannegan, K. C.
    Munoz, F. M.
    Das, S.
    Elliott, E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S275 - S275
  • [40] Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients
    Vilchez, R
    McCurry, K
    Dauber, J
    Iacono, A
    Keenan, R
    Griffith, B
    Kusne, S
    TRANSPLANTATION, 2002, 73 (07) : 1075 - 1078
12345